Introduction

Fat transplantation is an important treatment strategy for maxillofacial soft tissue deficiency, considering its excellence of biocompatibility and compliance in soft-tissue augmentation [1]. However, despite the ideal therapeutic proposal, several practical issues currently serve as roadblocks in the path. Unpredictable absorption rate is a major challenge for the application of fat transplantation procedure nowadays. The reported incidence varies, ranging from 30 to 70% among different cohorts [2]. Furthermore, transplant calcification, cyst and necrosis due to excessive single fat injection and poor angiogenesis may also contribute to poor prognosis of fat transplantation [3, 4]. It has been demonstrated that adipose tissue survival mainly depends on the neovascularization at the early stage of in vivo transplantation, as controlled by diverse pro-angiogenic factors. In recent years, concentrated platelet products, such as PRP and CGF, have been used as autologous materials to improve the fat survival rate [5,6,7,8,9,10] and have attracted increased attention [11,12,13,14,15,16,17]. In this study, we explored the effectiveness and safety of liquid phase concentrated growth factor (LPCGF) in promoting autologous fat graft survival and compared the effect of the main components to that of platelet-rich plasma (PRP).

Materials and Methods

Preparation of Free Fats

A volunteer was recruited from the Department of Oral and Craniomaxillofacial Surgery, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiaotong University. After receiving a conventional physical and laboratory tests to exclude underlying diseases, the volunteer signed the informed consent form and donated 30 ml of fat and 60 ml of peripheral venous blood for three separate times.

Animals

Twenty-four 4-week-old experimental-level NU/NU male nude mice (Shanghai SLAC Experimental Animals Co., Ltd., China) with body weights ranging from 18 to 24 g were selected. All nude mice had freely available food and water. The experiment started one week after all mice were housed in the SPF-level animal laboratory. Twenty-four nude mice were numbered 1–24 and then divided into eight groups. The mixture of LPCGF and fat and the mixture of PRP and fat were prepared for injection into the PRP group. LPCGF and PRP were prepared using the donated blood from the volunteer as described before [18, 19].

Fat Transplantation

The collected fat was divided into eight portions with 0.8 ml in each portion, and each portion was placed into a 2 ml syringe. The groups were labeled as control, CGF1, CGF2, CGF3, control, PRP1, PRP2 and PRP3. Fat was mixed with LPCGF or PRP at various proportions (blank, 1:8, 1:4 and 1:2; volume/volume). The transplant mixture (0.2 ml fat and LPCGF or fat and PRP at the corresponding proportions) was subcutaneously injected into the upper left, lower left, lower right and upper right areas of the backs of the nude mice with the corresponding numbers: The upper left, lower left, lower right and upper right areas on the backs of the No. 1, 2 and 3 nude mice were injected with the control, CGF1, CGF2 and CGF3 samples, respectively; the upper left, lower left, lower right and upper right areas of the backs of the nude mice marked No. 1 were injected with the control, PRP1, PRP2 and PRP3 samples, respectively, and the remaining experiments were performed in the same manner. After injection, the masses of the empty syringes were weighed, and the transplant masses were recorded (Table 1). Six nude mice were killed at each time point (15 d, 30 d, 45 d and 60 d), and all four transplanted fat samples were removed from subcutaneous tissue on the back of each nude mouse for further analysis. Tissues were harvested post-implantation to calculate the residual rate.

Table 1 Average residual rate of the residual mass of the transplanted fat in all groups at different times (%)

Histological Evaluation

Nude mice were killed through carbon dioxide suffocation at different time points and transplantation material harvested. After weighing and general observation, the obtained materials were fixed in 4% paraformaldehyde, dehydrated and embedded in paraffin. Serial sections of the tissue blocks were processed, stained and photographed with digital camera.

After H&E staining, the central necrosis degree, inflammatory reaction and cytolysis of the transplant were evaluated under a 10× microscope, and the scores were recorded by levels. Scoring criteria were as follows: 5 scores, unseen; 4 scores, mild manifestation; 3 scores, mild and moderate manifestation; 2 scores, moderate manifestation; 1 score, moderate and severe manifestation; 0 score, severe manifestation. The fibrosis degree of transplant tissues was evaluated under a 10× microscope. Scoring criteria are contrary to those specified above.

Immunohistochemistry and Immunofluorescence Staining

The following primary and secondary antibodies were used for cell immunohistochemistry and immunofluorescence staining: CD34+ monoclonal antibody, VEGF monoclonal antibody, TGF-β monoclonal antibody, biotin-labeled IgG antibody, Alexa Fluor® 568 goat anti-rabbit IgG, Fluor® 488 goat anti-mouse IgG antibody, 4,6-diamidino-2-phenylindole dihydrochloride. The staining protocols were described elsewhere [20, 21].

Images were acquired. The staining intensities and fluorescence intensities were quantified and analyzed with ImageJ software.

Results

Comparison of Fat Transplant Survival Rates

The initial mass (g) and residual mass of the fat transplants in three groups at different time points were recorded, and the residual ratios were calculated (Table 1). As no differences were observed among different PRP groups and the control group (data not shown) in fat survival and other indexes, PRP1 group, PRP2 group and PRP3 group were merged for data analysis to avoid redundancy and distraction and labeled as PRP group only in all results. Through analysis of variance of independent samples, differences in the fat transplant survival rates between the LPCGF group and PRP group with different proportions during different time periods were compared, and the following results were obtained (Fig. 1a, b).

Fig. 1
figure 1

The neovascularization in an H&E staining image for transplanted fat (×400) and statistical analysis. a The red arrows show the new vessel. b The line chart of the new vessel; at all times, the CGF groups showed higher values than the others

(1) After 30 days, the average absorption rate in the LPCGF group was the lowest, and the PRP group showed no obvious difference from the blank control group; the absorption rates of the CGF2 and CGF3 groups were significantly lower than those of the PRP group (p < 0.05). At 60 days, the absorption rates of the CGF1, CGF2 and CGF3 groups were significantly lower than those of the PRP group or blank control group (p < 0.05).

Observation and Scoring Results Based on H&E Staining of the Fat Transplant

No obvious differences existed in the CGF groups in the quantity of new vessels in the fat transplant tissues (Fig. 2a, b). Since the early phase, significant differences existed between the LPCGF groups and the PRP group. The LPCGF group with the lowest concentration of vessels still had more than those in the PRP group, and thus, LPCGF could obviously promote the formation of new vessels and improve the survival of the fat transplant. The quantity of new vessels in the same fat transplant showed few changes at different time points, and the promoting effects of LPCGF and PRP were mainly exerted within 15 days.

Fig. 2
figure 2

H&E staining images of fat grafts of the five groups obtained at 30 and 60 days after transplantation (×400) a Statistical analysis of the histological score b Significant differences were found among the normal saline (NS) group, PRP group and CGF groups. *p < .05, **p < .01, ***p < 0.001

Through a quantitative comparison of the histological manifestations of the fat transplant, fat liquefaction ranges in the LPCGF and PRP groups were smaller than those in the blank control group in the early phase, and obvious fibrotic septa appeared between cells that appeared earlier with more new vessel formation and were more obvious in the LPCGF groups than the other groups. However, no obvious differences existed in the inflammatory reactions between the adipose tissues and cellular morphological changes. The higher the proportion of LPCGF to fat, the better the transplantation performed, but when these transplants were compared with the transplant with a low concentration of LPCGF (1:8), there was no significant difference (Fig. 3).

Fig. 3
figure 3

Statistical analysis of the CD34-positive area. Significant differences were found among the normal saline (NS) group, PRP group and CGF groups. *p < .05, **p < .01, ***p < 0.001

Immunohistochemical Staining of CD34

After immunohistochemical staining, DAB-labeled CD34-positive stem cells were observed under a microscope (Fig. 4a). Most staining sites were located in new vessels, and some were inside the fibrous septum between fats. The staining area was calculated. Based on one-way analysis of variance, the staining areas of all LPCGF groups were significantly larger than those of the PRP group and blank control group at four time points, and no significant difference existed between the PRP group and blank control group (Fig. 4b).

Fig. 4
figure 4

a Expression of VEGF and TGF-β (×100). b Statistical analysis of the fluorescent intensity of VEGF and TGF-β. Significant differences were found among the normal saline (NS) group, PRP group and CGF groups. *p < .05, **p < .01, ***p < 0.001

For the intragroup comparison (LPCGF groups), there were no significant differences in CD34-positive stem cells in the different groups (different proportions of LPCGF). No obvious changes occurred as time passed. Correlation analysis between the staining areas in the groups and the quantities of new vessels was conducted. The correlation coefficient reached 0.71 (p < 0.01); thus, CD34-positive stem cells presented a significant correlation with the quantity of new vessels.

Results of VEGF and TGF-β Immunofluorescent Intensities

After immunofluorescence staining, TGF-β showed red fluorescence and VEGF showed green fluorescence, and the cell nucleus showed blue fluorescence. Two cytokines were mostly located in intercellular regions (Fig. 4a).

Compared with the PRP and blank control groups at the same time point, the LPCGF group had higher levels of VEFG and TGF-β. The higher the proportions of LPCGF, the higher the fluorescent intensities of the two cytokines. At different time points, the contents of both cytokines in the LPCGF groups, PRP group and blank control group slightly declined with time, but the differences were not significant (Fig. 4b). A correlation analysis of the two cytokines and histological scores in part two was conducted. The correlation coefficient between the VEGF fluorescence intensity and the score reached 0.55 (p < 0.01), while that between the TGF-β fluorescence intensity and the score was 0.57 (p < 0.01).

Discussion

Analysis of the Mass Change in Fat Transplants

One highlight of the current study is that we took a step forward to analyze the auxiliary effects of CGF in fat graft survival at different doses, on the basis that a wide variety of studies have already revealed the role of PRP. According to our experiment, the absorption degree of adipose tissues with time was an intuitive index. The results showed that CGF reduced the absorption of fat transplants, and the fat absorption rate in the blank control group was similar to clinically reported data, which further supported this conclusion. However, we could not ensure that only transplants without adipose tissues were obtained from nude mice and that there was no transplant loss. Thus, certain errors existed in the experimental results. Furthermore, in terms of experimental design, if a large animal experiment was adopted and materials were taken from the same body continuously, the experimental results would show an increased reliability.

Relationship Between New Vessels in the Fat Transplant and Survival Rate

There are two viewpoints regarding the outcome of fat transplantation: (1) transplanted fat cannot survive, and adipose tissues experience fibrosis [22, 23]; (2) transplanted fat can survive and is present for a long period of time due to sufficient blood supply and nutrition. In this study, the results of the blank control group indicated that subcutaneous blood supply on the back of the nude mice was not abundant, which inhibited the survival of adipocytes; however, new vessels increased in the tissues following LPCGF addition, and they became basically stable from 45 to 60 days. Existing animal experiments have reported that PRP also has a similar effect, and the fat transplant stably grows in the nude mouse body until 90 days. What’s more, we failed to observe the onset of fibrosis in this study, maybe because of the relatively short experimental duration and the low injection dose.

In this study, the quantities of new vessels in all CGF groups were significantly higher than those in the PRP and blank control groups, and the quantity was directly proportional to the results in the first experimental part and the other experiments in this part. Thus, the effect exerted by the generation of new vessels on the survival of the fat transplant was confirmed. A previous biological study on autologous fat transplantation-induced vascularization indicated [24] that some cytokines play significant roles in improving the survival rate of ischemic tissues, and VEGF is a powerful angiogenic factor that can obviously promote initial angiogenesis with high conservatism, stimulate the migration of endothelial cells and maintain the normal state of blood vessels. Thus, the content and effect of VEGF in LPCGF will be further investigated.

PRP has been speculated to improve the fat retention rate in autologous fat transplantation by a wide variety of research [25]. Although PRP was proved able to release growth factors and subsequently facilitate angiogenesis in vivo, the duration period of this biological action was documented only lasting for 8 days after implantation [2]. In the current study, the PRP group seems a little bit superior to control in terms of average residual mass of transplanted fat at 60 d, but no significant differences were observed. Here, we offer several explanations for this phenomenon. First, the biological action of PRP may be too short after implantation to influence the long-term (60 d) fat survival. In a sense, this is the reason why we aim to explore the application value of LPCGF and compare it with PRP. Second, we collected blood samples from one single volunteer, which may lead to selection bias. In future studies, we would expand the sample size and recruit volunteers with different demographic features from different centers. Last but not least, we chose a classical isolation method, which may potentially influence the biological capacities of PRP.

Relationship Between CD34-Positive Stem Cells and Fat Transplantation

CD34 is mainly expressed on the surface of hematopoietic stem cells (HSCs) in blood and primarily maintains the stability of blood compositions through differentiation of mature hemocytes; this molecule also plays a role in regulating and maintaining the physiological equilibrium of cell components in the tissue under stress states such as injury and inflammation. A major advantage of LPCGF is that it contains CD34-positive stem cells, which are not contained in PRP.

In this study, CD34 was expressed in the fat transplant, and LPCGF contained high levels of CD34-positive cells. The promoting effect of HSCs on the survival rate of fat transplantation has seldom been discussed so far, and most studies have positive attitudes toward it [26]. However, CD34 will also be expressed in endothelial cells in new vessels; thus, its positive expression could also be observed in the PRP groups. VEGF in LPCGF can obviously promote angiogenesis; thus, this study cannot prove that the LPCGF-mediated improvement in the survival rate of fat transplantation has a direct bearing on CD34-positive stem cells, and further experimental exploration is needed.

Conclusion

Complete fat transplantation operations provide a safer and more natural operation mode for soft tissue restoration, but the limitations of high fat absorption rates and the low levels of transplanted material remain a challenge. LPCGF, which is rich in various growth factors, has gained increased attention. In this study, the results demonstrated the following conclusions:

  1. (1)

    LPCGF is safe and effective when applied to autologous fat transplantation.

  2. (2)

    When compared to PRP, LPCGF has a greater promoting effect on fat transplantation, and its effect is obvious when the proportion of LPCGF/fat tissues is 1:8. Increasing the proportion of LPCGF does not significantly improve the fat transplantation effect. In consideration of the clinically collected blood quantity and the quantity needed for fat transplantation, a proportion of 1:8 is recommended.

  3. (3)

    LPCGF is rich in VEGF, TGF-β and CD34-positive stem cells, which can improve the fat transplantation effect, but the specific influence of a single component requires future evaluation.